Co-Dalneva 4 mg/1,25 mg/10 mg tablete
| Name | Co-Dalneva 4 mg/1,25 mg/10 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-622847904 |
| Active Substance | perindopril-tert-butilamin indapamid amlodipinbesilat |
| Composition | svaka tableta sadrži 4 mg perindopril-tert-butilamina što odgovara 3,34 mg perindoprila, 1,25 mg indapamida i 10 mg amlodipina u obliku amlodipinbesilata |
| Pharmaceutical Form | tableta |
| Manufacturer | Krka d.d., Novo mesto, Novo Mesto, Slovenija |
| Marketing Authorisation Holder | Krka - farma d.o.o., Radnička cesta 48, Zagreb, Hrvatska |
| Marketing Authorisation Date | 29.11.2022 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/21-02/200 |
| Registration Number | 381-12-01/154-22-04 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C09BX01 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
